Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

In vivo animal stroke models: a rationale for rodent and non-human primate models.

Tajiri N, Dailey T, Metcalf C, Mosley YI, Lau T, Staples M, van Loveren H, Kim SU, Yamashima T, Yasuhara T, Date I, Kaneko Y, Borlongan CV.

Transl Stroke Res. 2013 Jun;4(3):308-21. doi: 10.1007/s12975-012-0241-2. Review.

2.

Transplantation for stroke.

Roitberg B.

Neurol Res. 2004 Apr;26(3):256-64. Review.

PMID:
15142317
3.

Stem cells in stroke repair: current success and future prospects.

Gopurappilly R, Pal R, Mamidi MK, Dey S, Bhonde R, Das AK.

CNS Neurol Disord Drug Targets. 2011 Sep 1;10(6):741-56. Review.

PMID:
21838668
4.

Rodent models of hemorrhagic stroke.

Strbian D, Durukan A, Tatlisumak T.

Curr Pharm Des. 2008;14(4):352-8. Review.

PMID:
18289061
5.

Magnetic resonance imaging of perfusion-diffusion mismatch in rodent and non-human primate stroke models.

Duong TQ.

Neurol Res. 2013 Jun;35(5):465-9. doi: 10.1179/1743132813Y.0000000211. Review.

6.

Cell therapy for stroke: remaining issues to address before embarking on clinical trials.

Borlongan CV.

Stroke. 2009 Mar;40(3 Suppl):S146-8. doi: 10.1161/STROKEAHA.108.533091. Review.

7.

[Animal models of cerebral ischemia--testing therapeutic strategies in vivo].

Erdô F, Hossmann KA.

Ideggyogy Sz. 2007 Sep 30;60(9-10):356-69. Review. Hungarian.

PMID:
17987730
8.

Nonhuman primate models of stroke for translational neuroprotection research.

Cook DJ, Tymianski M.

Neurotherapeutics. 2012 Apr;9(2):371-9. doi: 10.1007/s13311-012-0115-z. Review.

9.

Rodent models of ischemic stroke lack translational relevance... are baboon models the answer?

Kwiecien TD, Sy C, Ding Y.

Neurol Res. 2014 May;36(5):417-22. doi: 10.1179/1743132814Y.0000000358. Review.

PMID:
24649811
10.

[In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].

Lestage P, Lockhart B, Roger A.

Therapie. 2002 Nov-Dec;57(6):554-63. Review. French.

PMID:
12666263
11.

Bioethical considerations in translational research: primate stroke.

Sughrue ME, Mocco J, Mack WJ, Ducruet AF, Komotar RJ, Fischbach RL, Martin TE, Connolly ES Jr.

Am J Bioeth. 2009 May;9(5):3-12. doi: 10.1080/15265160902788652.

PMID:
19396671
12.

Human stem cell therapy in ischaemic stroke: a review.

Banerjee S, Williamson D, Habib N, Gordon M, Chataway J.

Age Ageing. 2011 Jan;40(1):7-13. doi: 10.1093/ageing/afq133. Review.

13.
14.

Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

Durukan A, Tatlisumak T.

Pharmacol Biochem Behav. 2007 May;87(1):179-97. Review.

PMID:
17521716
15.

Nonhuman primate models in translational regenerative medicine.

Daadi MM, Barberi T, Shi Q, Lanford RE.

Stem Cells Dev. 2014 Dec;23 Suppl 1:83-7. doi: 10.1089/scd.2014.0374.

16.

New targets of neuroprotection in ischemic stroke.

Bacigaluppi M, Hermann DM.

ScientificWorldJournal. 2008 Jul 13;8:698-712. doi: 10.1100/tsw.2008.94. Review.

17.

Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.

Tang YH, Ma YY, Zhang ZJ, Wang YT, Yang GY.

CNS Neurosci Ther. 2015 Apr;21(4):337-47. doi: 10.1111/cns.12386. Review.

PMID:
25676164
18.

Animal models.

Small DL, Buchan AM.

Br Med Bull. 2000;56(2):307-17. Review.

19.

Regenerative medicine for stroke - are we there yet?

Onteniente B, Polentes J.

Cerebrovasc Dis. 2011;31(6):544-51. doi: 10.1159/000324325. Review.

20.

[Neuroprotection in brain ischemia--doubts and hopes].

Zádor Z, Benyó Z, Lacza Z, Hortobágyi T Sr, Harkány T, Hortobágyi T.

Ideggyogy Sz. 2004 Mar 20;57(3-4):81-93. Review. Hungarian.

PMID:
15133909
Items per page

Supplemental Content

Support Center